Cargando…
Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
Amyotrophic Lateral Sclerosis (ALS) is a highly debilitating disease caused by progressive degeneration of motorneurons (MNs). Due to the wide variety of genes and mutations identified in ALS, a highly varied etiology could ultimately converge to produce similar clinical symptoms. A major hypothesis...
Autores principales: | Campanari, Maria-Letizia, García-Ayllón, María-Salud, Ciura, Sorana, Sáez-Valero, Javier, Kabashi, Edor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187284/ https://www.ncbi.nlm.nih.gov/pubmed/28082868 http://dx.doi.org/10.3389/fnmol.2016.00160 |
Ejemplares similares
-
Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis
por: Campanari, Maria-Letizia, et al.
Publicado: (2019) -
TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish
por: Campanari, Maria-Letizia, et al.
Publicado: (2021) -
The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway
por: Ciura, Sorana, et al.
Publicado: (2016) -
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
por: Cappello, Valentina, et al.
Publicado: (2017) -
Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
por: Miccio, Annarita, et al.
Publicado: (2022)